1. 2023
  2. Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors.

    Martens, A. W. J., Kavazović, I., Krapić, M., Pack, S. M., Arens, R., Jongejan, A., Moerland, P. D., Eldering, E., van der Windt, G. J. W., Wensveen, F. M., Peters, F. S. & Kater, A. P., 19 Jan 2023, In: Leukemia. p. 1-11 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019

    van der Straten, L., Levin, M-D., Dinnessen, M. A. W., Visser, O., Posthuma, E. F. M., Doorduijn, J. K., Langerak, A. W., Kater, A. P. & Dinmohamed, A. G., 13 Jan 2023, In: Blood cancer journal. 13, 1, p. 15 1 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: a randomized, controlled trial

    Huygens, S., Hofsink, Q., Nijhof, I. S., Goorhuis, A., Kater, A. P., Te Boekhorst, P. A., Swaneveld, F., Novotný, V. M., Bogers, S., Welkers, M. R., Papageorgiou, G., Rijnders, B. J. & Heijmans, J., 11 Jan 2023, In: The Journal of infectious diseases. 227, 2, p. 206-210 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. 2022
  6. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

    Antic, D., Milic, N., Chatzikonstantinou, T., Scarfò, L., Otasevic, V., Rajovic, N., Allsup, D., Alonso Cabrero, A., Andres, M., Baile Gonzales, M., Capasso, A., Collado, R., Cordoba, R., Cuéllar-García, C., Correa, J. G., De Paoli, L., De Paolis, M. R., Del Poeta, G., Dimou, M., Doubek, M., & 81 othersEfstathopoulou, M., El-Ashwah, S., Enrico, A., Espinet, B., Farina, L., Ferrari, A., Foglietta, M., Lopez-Garcia, A., García-Marco, J. A., García-Serra, R., Gentile, M., Gimeno, E., da Silva, M. G., Gutwein, O., Hakobyan, Y. K., Herishanu, Y., Hernández-Rivas, J. Á., Herold, T., Itchaki, G., Jaksic, O., Janssens, A., Kalashnikova, O. B., Kalicińska, E., Kater, A. P., Kersting, S., Koren-Michowitz, M., Labrador, J., Lad, D., Laurenti, L., Fresa, A., Levin, M-D., Mayor Bastida, C., Malerba, L., Marasca, R., Marchetti, M., Marquet, J., Mihaljevic, B., Milosevic, I., Mirás, F., Morawska, M., Motta, M., Munir, T., Murru, R., Nunes, R., Olivieri, J., Pavlovsky, M. A., Piskunova, I., Popov, V. M., Quaglia, F. M., Quaresmini, G., Reda, G., Rigolin, G. M., Shrestha, A., Šimkovič, M., Smirnova, S., Špaček, M., Sportoletti, P., Stanca, O., Stavroyianni, N., Te Raa, D., Tomic, K., Tonino, S., Trentin, L., Van Der Spek, E., van Gelder, M., Varettoni, M., Visentin, A., Vitale, C., Vukovic, V., Wasik-Szczepanek, E., Wróbel, T., Segundo, L. Y. S., Yassin, M., Coscia, M., Rambaldi, A., Montserrat, E., Foà, R., Cuneo, A., Carrier, M., Ghia, P. & Stamatopoulos, K., Dec 2022, In: JOURNAL OF HEMATOLOGY & ONCOLOGY. 15, 1, p. 116 116.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma

    Leeksma, A. C., Derks, I. A. M., Garrick, B., Jongejan, A., Colombo, M., Bloedjes, T., Trowe, T., Leisten, J. C., Howarth, M., Malek, M., Mortensen, D. S., Blease, K., Groza, M. C., Narla, R. K., Loos, R., Kersten, M-J., Moerland, P. D., Guikema, J. E. J., Kater, A. P., Eldering, E., & 1 othersFilvaroff, E. H., 18 Nov 2022, (E-pub ahead of print) In: Molecular oncology.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation

    Thus, Y. J., De Rooij, M. F. M., Swier, N., Beijersbergen, R. L., Guikema, J. E. J., Kersten, M-J., Eldering, E., Pals, S. T., Kater, A. P. & Spaargaren, M., 13 Oct 2022, (E-pub ahead of print) In: Haematologica.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

    COBRA KAI Study Team, Haggenburg, S., Hofsink, Q., Lissenberg-Witte, B. I., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., Burger, J. A., Bouhuijs, J. H., Smits, G. P., Wouters, D., van Leeuwen, E. M. M., Bontkes, H. J., Kootstra, N. A., Zweegman, S., Kater, A. P., Heemskerk, M. H. M., & 9 othersGroen, K., van Meerten, T., Mutsaers, P. G. N. J., Beaumont, T., van Gils, M. J., Goorhuis, A., Rutten, C. E., Hazenberg, M. D. & Nijhof, I. S., 1 Oct 2022, In: JAMA oncology. 8, 10, p. 1477-1483 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study

    Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M-D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, Q., Steele, A., Schuier, N., Baeten, K., Caces, D. B., & 2 othersNiemann, C. & Kater, A., 1 Oct 2022, In: Clinical lymphoma, myeloma & leukemia. 22, p. S264-S265

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma

    Thus, Y. J., Eldering, E., Kater, A. P. & Spaargaren, M., Sep 2022, In: Leukemia. 36, 9, p. 2165-2176 12 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  12. Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

    Seymour, J. F., Kipps, T. J., Eichhorst, B. F., D'Rozario, J., Owen, C. J., Assouline, S., Lamanna, N., Robak, T., de la Serna, J., Jaeger, U., Cartron, G., Montillo, M., Mellink, C., Chyla, B., Panchal, A., Lu, T., Wu, J. Q., Jiang, Y., Lefebure, M., Boyer, M., & 1 othersKater, A. P., 25 Aug 2022, In: Blood. 140, 8, p. 839-850 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...21 Next

ID: 64520